Sarepta Therapeutics(SRPT) - 2022 Q3 - Earnings Call Transcript

Sarepta Therapeutics, Inc. (NASDAQ:SRPT) Q3 2022 Results Conference Call November 2, 2022 4:30 PM ET Company Participants Mary Jenkins - Senior Manager, IR Doug Ingram - President and CEO Ian Estepan - EVP and CFO Dallan Murray - SVP and Chief Customer Officer Dr. Louise Rodino-Klapac - EVP, Head of R&D and Chief Scientific Officer Conference Call Participants Gena Wang - Barclays Tazeen Ahmad - BofA Gil Blum - Needham & Company Colin Bristow - UBS Matthew Harrison - Morgan Stanley Brian Abrahams - RBC Bria ...